Last news
IIIF150 Unveils Latest Flagship Raptor 5G at MWC2025

IIIF150 Unveils Latest Flagship Raptor 5G at MWC2025

BARCELONA, Spain, Feb. 25, 2025 /PRNewswire/ -- IIIF150, the imaginative ultra-thin rugged phone manufacture, announced their new flagship Raptor 5G which will be showcased in Barcelona, and different tests onsite to challenge the durability...

Flexport Unveils 20+ Tech and AI-Powered Products to Modernize Global Supply Chains

Flexport Unveils 20+ Tech and AI-Powered Products to Modernize Global Supply Chains

At the forefront of the launch are Flexport Intelligence with an AI Insights Builder, and Flexport Control Tower expanding supply chain visibility and management capabilities. SAN FRANCISCO, Feb. 25, 2025 /PRNewswire/ -- Flexport, the global leader...

DXC tapped by Skanska to Modernize Global IT Infrastructure

DXC tapped by Skanska to Modernize Global IT Infrastructure

ASHBURN, VA, Feb. 25, 2025 /PRNewswire/ -- DXC Technology, (NYSE: DXC), a leading Fortune 500 global technology services provider, has signed an agreement with Skanska AB, a multinational construction and project development leader, to modernize...

India's Bharti Airtel partners Ericsson 5G Core technology to drive 5G evolution

India's Bharti Airtel partners Ericsson 5G Core technology to drive 5G evolution

New agreement spans packet core, signaling, charging & policy solutions STOCKHOLM, Feb. 25, 2025 /PRNewswire/ -- India's Bharti Airtel and Ericsson (NASDAQ: ERIC) have strengthened their longstanding partnership through a new collaboration to...

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI, Feb. 23, 2025 /PRNewswire/ -- BioCity Biopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist, SC0062, met the 12-week primary endpoint of a reduction in proteinuria in the diabetic kidney disease (DKD)...

China committed to acting as an 'enabler'

China committed to acting as an 'enabler'

BEIJING, Feb. 25, 2025 /PRNewswire/ -- A report from People's Daily: Recently, a foreign scholar described China as an "enabler." This term vividly encapsulates China's commitment to building a community with a shared future for mankind and...

Kerry Establishes Local Manufacturing Partnership for Taste Solutions in Pakistan

Kerry Establishes Local Manufacturing Partnership for Taste Solutions in Pakistan

KARACHI, Pakistan, Feb. 25, 2025 /PRNewswire/ -- Kerry, a global leader in taste and nutrition, has partnered with Far Eastern Impex (FEI) to open the first international production operation for flavourings in Pakistan. The manufacturing facility,...

How 51Talk is Redefining Online Education Through AI--from the Boardroom to the Classroom

How 51Talk is Redefining Online Education Through AI--from the Boardroom to the Classroom

SINGAPORE, Feb. 25, 2025 /PRNewswire/ -- 51Talk, an online English language education platform, has announced plans to launch a comprehensive, AI-powered systems upgrade across its business operations within the coming months. Partnering with top...

menu
menu